Zeenome Information

Zeenome Longevity focuses on transforming cutting-edge longevity science and technology into practical health products and services, promoting a healthy long life. We're backed by two prominent players in the medical diagnostics and supplement industries, and we've been pioneers in healthy aging since 2022. We launched our service in early 2023, and it has already helped our clients improve their health and slow down the aging process. We employ a combination of advanced AI-powered diagnostics (providing clarity on the factors influencing their aging), medical supervision, lifestyle changes, and personalized supplement diets in a tailored health and wellness plan to assist individuals concerned about their healthy aging journey. In 2022 and 2023, our investors actively participated in the Swiss Longevity Investors Conference, fostering connections within the longevity science and industry community. Then, we've cultivated a longevity community, uniting enthusiasts from investment, scientific, and academic realms to enhance collaboration and synergy. We also partner with other leading organizations in aging-related fields, such as Stem Cell research to develop new technologies and possibilities. We invest in new technologies and businesses aligned with our mission, such as AI-powered diagnostics, microbiome products, epigenetic tests, etc. Our reach extends, as we are set to expand our business and key partnerships to the UAE and the UK in 2024, aiming to grow our network further and enhance the impact of our high-quality products and services.